通过胸电阻抗测量肥胖女性服用右芬氟拉明和育亨宾后的心血管变化。
Cardiovascular changes after treatment with dexfenfluramine and yohimbine in obese women measured by thoracic electrical bioimpedance.
作者信息
Waluga M, Janusz M, Karpel E, Hartleb M, Nowak A
机构信息
Department of Gastroenterology, Silesian Medical Academy, Katowice, Poland.
出版信息
Boll Chim Farm. 1999 Jul-Aug;138(7):359-63.
PMID:10597657
Abstract
An anorectic drug, dexfenfluramine (dF) is commonly used in obesity treatment. The aim of our study was to investigate if dexfenfluramine used alone or together with alpha 2-adrenolitic yohimbine (Y), can change cardiovascular state in obese women.
摘要
一种食欲抑制剂药物，右芬氟拉明（dF）常用于肥胖症治疗。我们研究的目的是调查单独使用右芬氟拉明或与α2 -肾上腺素能阻断剂育亨宾（Y）联合使用是否会改变肥胖女性的心血管状态。
Zotero 插件